Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
  • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
  • A61K8/89—Polysiloxanes
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
  • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
  • A61K8/89—Polysiloxanes
  • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
  • A61K8/04—Dispersions; Emulsions
  • A61K8/042—Gels
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
  • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
  • A61K8/89—Polysiloxanes
  • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
  • A61K8/894—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a polyoxyalkylene group, e.g. cetyl dimethicone copolyol
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
  • A61Q1/02—Preparations containing skin colorants, e.g. pigments
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
  • A61Q1/02—Preparations containing skin colorants, e.g. pigments
  • A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
  • A61Q1/02—Preparations containing skin colorants, e.g. pigments
  • A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
  • A61Q1/06—Lipsticks
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q15/00—Anti-perspirants or body deodorants
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q19/00—Preparations for care of the skin
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q5/00—Preparations for care of the hair
  • A61Q5/12—Preparations containing hair conditioners
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
  • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
  • A61K2800/54—Polymers characterized by specific structures/properties
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
  • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
  • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms

Definitions

• the present invention relates to silicone compositions, more particularly to compositions comprising a silicone polymer network comprising cross-links derived from epoxide or oxirane moieites.
• the personal care industry thrives on being able to deliver multiple performance products based on mixtures of several components, with each having performance characteristics important to or desirable in the final formulation.
• One desirable characteristic is the ability to provide a silky initial feel derived from low molecular weight silicones, such as for example, octamethylcyclotetrasilioxane or decamethylcyclopentasiloxane, in the formulation while maintaining a high, but shear-thinnable viscosity. While these low molecular weight silicones provide the desired feel characteristics, they are also low viscosity, highly flowable liquids. Thus they are not easily held in a formulation, preferring rather to separate and flow out of a given container or flow uncontrollably across the skin when used in a specific application.
• Such polymeric silicone gels have typically been made by the hydrosilylation reaction, which requires the use of both SiH functional groups and terminal olefinic groups to form crosslinked siloxane polymers.
• siloxane structures that can incorporate silylhydride groups and optionally, vinyl functional siloxane groups, can be utilized in making these materials.
• this method of generating crosslinked siloxane polymers limits the range of desirable organofunctional groups that may be incorporated into the polymeric structure to create additional performance advantages in complex formulations.
• attempts to include organofunctional groups into the crosslinked siloxane polymer include unsaturated organic groups compatible with the hydrosilylaton reaction.
• a cosmetic composition comprising the reaction products of
• M H R 4 R 5 R SiO ⁇ / 2 ;
• M E R 6 R 7 R E SiO ⁇ 2 ;
• T E R E SiO 3 /2;
• R 1 , R 2 , R 3 , R 8 , R 9 and R 12 are independently monovalent hydrocarbon radicals having from one to sixty carbon atoms;
• R 4 , R 5 and R 10 are independently monovalent hydrocarbon radicals having from one to sixty carbon atoms or hydrogen;
• R 6 , R 7 , R ⁇ are independently monovalent hydrocarbon radicals having from one to sixty carbon atoms or R E ;
• each R E is independently a monovalent hydrocarbon radical containing one or more oxirane moieties having from one to sixty carbon atoms;
• the stoichiometric subscripts a, b, c, d, e, f, g, h, i, and j are either zero or positive subject to the following limitations: a + b + c > l; b + e + h > l; c + f + i > l; b + e + h > c + f
• reaction product of the present invention is a polyether siloxane copolymer network.
• reaction product of the present invention is a polyether siloxane copolymer network swollen with a volatile low molecular weight silicon containing compound.
• compositions of the present invention comprise the reaction products of an epoxy functional hydrido siloxane molecule having the following formula:
• M H R 4 R 5 H SiO ⁇ / 2 ;
• T R 12 SiO 3 / 2 ;
• R 1 , R 2 , R 3 , R 8 , R 9 and R 12 are independently monovalent hydrocarbon radicals having from one to sixty carbon atoms;
• R 4 , R 5 and R 10 are independently monovalent hydrocarbon radicals having from one to sixty carbon atoms or hydrogen;
• R 6 , R , R ⁇ are independently monovalent hydrocarbon radicals having from one to sixty carbon atoms or R E ;
• each R E is independently a monovalent hydrocarbon radical containing one or more oxirane moieties having from one to sixty carbon atoms;
• the stoichiometric subscripts a, b, c, d, e, f, g, h, i, and j are either zero or positive subject to the following limitations: a + b + c > l; b + e + h > l; c + f + i > l; b + e + h > c + f + i; and when d +
• One method of producing the composition of the present invention is to react a molecule having the following formula:
• an olefinically unsaturated molecule containing one or more oxirane moieties means a molecule possessing one or more interior, pendant or terminal carbon carbon double bonds simultaneously with one or more interior, pendant or terminal three membered oxygen containing heterocyclic rings (chemically the phrase “three membered oxygen containing heterocyclic ring” is used herein interchangeably with the oxirane or epoxide structures).
• the simplest chemical structure exemplified by such a definition is:
• subscript k may be zero or a positive integer, more preferably a positive integer ranging generally from 0 to about 10. It should be noted that both exemplified structures are terminal in both the olefinic moiety and the oxirane (epoxide) moiety.
• a more general chemical structure is:
• R 13 , R 14 , R 15 , R 16 , R 17 and R 18 are each independently selected from the group of hydrogen and monovalent hydrocarbon radicals having from one to sixty carbon atoms
• Q m is a di- or trivalent hydrocarbon radical having from one to sixty carbon atoms
• Q n is a divalent hydrocarbon radical having from one to sixty carbon atoms with the subscripts m and n independently zero or one subject to the limitation that when Qm is trivalent one of R 13 or R 14 is absent and where R 16 and R 18 may be either cis- or trans- to each other.
• acetylene analogs of the olefinicaUy unsaturated oxirane containing molecules will produce similar species that will react to form similar products.
• an olefinically unsaturated molecule containing one or more oxirane moieties is intended to also include an acetylenically unsaturated molecule containing one or more oxirane moieties.
• an acetylenically unsaturated molecule containing one or more oxirane moieties is intended to also include an acetylenically unsaturated molecule containing one or more oxirane moieties.
• an acetylenically unsaturated molecule containing one or more oxirane moieties is intended to also include an acetylenically unsaturated molecule containing one or more oxirane moieties.
• an acetylenically unsaturated molecule containing one or more oxirane moieties is intended to also include an acetylenically unsaturated
• unsaturated molecule containing one or more oxirane moieties means a molecule possessing one or more interior, pendant or terminal carbon carbon triple bonds simultaneously with one or more interior, pendant or terminal three membered oxygen containing heterocyclic rings (chemically the phrase "three membered oxygen containing heterocyclic ring" is used herein interchangeably with the oxirane or epoxide structures).
• the epoxide compound is an olefinic epoxide, a specific example being:
• epoxide is an acetylenic epoxide, a specific example being:
• R E as a substituent, becomes either:
• the silyl hydride bearing precursor molecule MaM H b ' DdD H e'T g T H h'Qj, can be prepared by a variety of techniques known in the art.
• Epoxy substituted siloxanes are prepared in the normal manner through the use of a hydrosilylation reaction to attach a vinyl or allyl substituted epoxide onto an
• SiH bearing siloxane SiH containing siloxanes are well known in the art and can be linear, branched, or cyclic in structure.
• Examples of useful vinyl or allyl substituted epoxides include 4-vinyl cyclohexene oxide, allyl glycidyl ether, limonene oxide, l,2-epoxy-5-hexene, l,2-epoxy-7-octene, norbomadiene monoepoxide and l,2-epoxy-9-decene.
• Precious metal catalysts suitable for making epoxy siloxanes are also well known in the art and comprise complexes of rhodium, ruthenium, palladium, osmium, iridium and /or platinum.
• platinum catalysts for this SiH olefin addition reaction hydrosilation or hydrosilylation
• platinum catalysts may be used for the reaction in the present instance.
• the preferred platinum catalysts are those platinum compound catalysts that are soluble in the reaction mixture.
• the platinum compound can be selected from those having the formula (PtC ⁇ Olefin) and H(PtCl3 ⁇ lefin) as described in U.S. patent number 3,159,601, hereby incorporated by reference.
• a further platinum containing material usable in the compositions of the present invention is the cyclopropane complex of platinum chloride described in U.S. patent number 3,159,662 hereby incorporated by reference.
• the platinum containing material can be a complex formed from chloroplatinic acid with up to 2 moles per gram of platinum of a member selected from the class consisting of alcohols, ethers, aldehydes and mixtures of the above as described in U.S. patent number 3,220,972 hereby incorporated by reference.
• the catalysts preferred for use are described in U. S. Patents numbers 3,715,334; 3,775,452; and 3,814,730 to Karstedt. Additional background concerning the art may be found at J. L. Spier, "Homogeneous Catalysis of Hydrosilation by Transition Metals, in Advances in Organometallic Chemistry, volume 17, pages 407 through 447, F.G.A. Stone and R. West editors, published by the Academic Press (New
• an effective amount of platinum catalyst ranges from about 0.1 to 50 parts per million of the total organopolysiloxane composition.
• the reaction product of produces a polymer network, believed to be a polyether siloxane copolymer network (or alternativeley a siloxane polyether copolymer network).
• network means a three dimensionally extending structure comprising interconnected polyether siloxane copolymer chains.
• fluid is contained within interstices of the network.
• interstices is used herein in reference to a network to denote spaces within the network, that is, spaces between the polyether siloxane copolymer chains of the network.
• polyether is intended to include the reaction product of two or more epoxide moieties to form one or more ether linkages that form a cross link between siloxane chains or moieties.
• the polyether siloxane copolymer network is a crosslinked network that is insoluble in the fluid component of the silicone composition of the present invention, but that is capable of being swollen by the fluid.
• the amount of crosslinking present in the crosslinked network may be characterized with respect to the degree of swelling exhibited by the network in the fluid.
• the crosslinked structure of the network is effective to allow the network to be swollen by a low molecular weight silicone fluid, such as, for example, decamethylcyclopentasUoxane, from its original volume to a swollen volume that is a factor of from 1.01 to 5000, more preferably from 2 to 1000, and even more preferably from 5 to 500, times its original volume.
• the original volume of the network can be determined, for example, by extracting or evaporating aU of the fluid component from the silicone composition of the present invention to leave the original volume, that is, the volume of the polyether sUoxane copolymer network in the absence of the fluid.
• hydrocarbon radical includes acyclic hydrocarbon radicals, alicyclic hydrocarbon radicals and aromatic hydrocarbon radicals.
• a monovalent radical can be represented as having been derived from a saturated hydrocarbon compound by conceptual removal of one hydrogen atom from the compound
• a divalent radical can be represented as having been derived from a saturated hydrocarbon compound by conceptual removal of two hydrogen atoms from the compound
• a trivalent radical can be represented as having been derived from a saturated hydrocarbon compound by conceptual removal of three hydrogen atoms from the compound.
• an ethyl radical that is, a - CH2CH3 radical
• a dimethylene radical that is, a - (CH2)2 - radical
• an ethanetriyl radical that is,
• radical is a trivalent radical, each of which can be represented as having been derived by conceptual removal of one or more hydrogen atoms from the saturated hydrocarbon ethane.
• acyclic hydrocarbon radical means a straight chain or branched hydrocarbon radical, preferably containing from 1 to 60 carbon atoms per radical, which may be saturated or unsaturated and which may be optionally substituted or interrupted with one or more atoms or functional groups, such as, for example, carboxyl, cyano, hydroxy, halo and oxy.
• suitable monovalent acyclic hydrocarbon radicals may include, for example, alkyl, alkenyl, alkynyl, hydroxyalkyl, cyanoalkyl, carboxyalkyl, alkyloxy, oxaalkyl, alkylcarbonyloxaalkylene, carboxamide and haloalkyl, such as, for example, methyl, ethyl, sec-butyl, tert-butyl, octyl, decyl, dodecyl, cetyl, stearyl, ethenyl, propenyl, butynyl, hydroxypropyl, cyanoethyl, butoxy, 2,5,8- rrioxadecanyl, carboxymethyl, chloromethyl and 3,3,3-fluoropropyl.
• Suitable divalent acydic hydrocarbon radicals include, for example, linear or branched alkylene radicals, such as, for example, methylene, dimethylene, trimethylene, decamethylene, ethylethylene, 2-methyltrimethylene, 2,2- dimethyltrimethylene and linear or branched oxalkylene radicals such as, for example, methyleneoxypropylene.
• Suitable trivalent acycUc hydrocarbon radicals include, for example, alkanetriyl radicals, such as, for example, 1,1,2- ethanetriyl, 1,2,4-butanetriyl, 1,2,8-octanetriyl, 1,2,4-cyclohexanetriyl and oxaalkanetriyl radicals such as, for example, l,2,6-triyl-4-oxahexane.
• alkyl means a saturated straight or branched monovalent hydrocarbon radical.
• monovalent alkyl groups are selected from linear or branched alkyl groups containing from 1 to 60 carbons per group, such as, for example, methyl, ethyl, propyl, iso-propyl, n-butyl, iso-butyl, sec-butyl, tert-butyl, pentyl, hexyl, heptyl, decyl, dodecyl.
• alkenyl means a straight or branched monovalent terminaUy unsaturated hydrocarbon radical, preferably containing from 2 to 10 carbon atoms per radical, such as, for example, ethenyl, 2-propenyl, 3-butenyl, 5-hexenyl, 7-octenyl and ethenylphenyl.
• alicydic hydrocarbon radical means a radical containing one or more saturated hydrocarbon rings, preferably containing from 4 to 12 carbon atoms per ring, per radical which may optionally be substituted on one or more of the rings with one or more alkyl radicals, each preferably containing from 2 to 6 carbon atoms per alkyl radical, halo radicals or other functional groups and which, in the case of a monovalent alicyclic hydrocarbon radical containing two or more rings, may be fused rings.
• Suitable monovalent alicyclic hydrocarbon radicals include, for example, cyclohexyl and cyclooctyl.
• Suitable divalent hydrocarbon radicals include, saturated or unsaturated divalent monocyclic hydrocarbon radicals, such as, for example, 1,4-cyclohexylene.
• Suitable trivalent aUcyclic hydrocarbon radicals include, for example, cycloalkanetriyl radicals such as, for example, l-dimethylene-2, 4-cyclohexylene, l-methylethylene-3-methyl-
• aromatic hydrocarbon radical means a hydrocarbon radical containing one or more aromatic rings per radical, which may, optionaUy, be substituted on the aromatic rings with one or more alkyl radicals, each preferably containing from 2 to 6 carbon atoms per alkyl radical, halo radicals or other functional groups and which, in the case of a monovalent aromatic hydrocarbon radical containing two or more rings, may be fused rings.
• Suitable monovalent aromatic hydrocarbon radicals include, for example, phenyl, tolyl, 2,4,6-trimethylphenyl, 1,2- isopropylmethylphenyl, 1-pentalenyl, naphthyl, anthryl, eugenol and aUylphenol as weU as aralkyl radicals such as, for example, 2-phenylethyl.
• Suitable divalent aromatic hydrocarbon radicals include, for example, divalent monocyclic arenes such as, for example, 1,2-phenylene, 1,4- phenylene, 4-methyl-l,2-phenylene, phenylmethylene.
• Suitable trivalent aromatic hydrocarbon radicals include, for example, trivalent monocycUc arenes such as, for example, l-trimethylene-3.5-phenylene.
• the epoxy functional organosUoxane compound is reacted by polymerizing the epoxy functional organosUoxane compound under cationic polymerization conditions and, preferably, in the presence of a fluid, preferably a volatile sUoxane fluid.
• the epoxy functional organosUoxane compound is polymerized in the presence of a fluid to directly form the silicone composition of the present invention.
• the epoxy functional organosUoxane compound is polymerized in the presence of a first fluid or fluid mixture to form a polyether sUoxane copolymer network, and then the network so formed is subsequently swoUen with a second fluid or fluid mixture to form the sUicone composition of the present invention.
• the second fluid or fluid mixture may be the same as or different from the first fluid mixture.
• the first solvent may, optionaUy, be removed from the polymerized network by, for example, evaporation, prior to addition of the second fluid.
• the epoxy functional organosUoxane compound is polymerized in the absence of a fluid to form a polyether siloxane copolymer network and the network is subsequently swoUen with a fluid or mixture of fluids to form the silicone composition of the present invention.
• the polymerization of the epoxy functional organosUoxane is conducted with a sufficient amount of excess hydridosUoxane functionality such that there is residual hydride remaining after polymerization that may be subsequently reacted under conditions suitable for hydrosilylation with one or more alkenyl functional compounds. This is especially advantageous in cases where the alkenyl functional compounds can act as inhibitors of cationic cure.
• alkenyl compounds are those that contain a functionality that can act as an inhibitor of the cationic cure mechanism, e.g. a base.
• a small amount of a concentrated hydridosUoxane or hydridosUane compound is added in order to increase the rate of polymerization.
• Cationic polymerization conditions can be generated by addition of an acid catalyst capable of polymerizing an epoxy group such as, for example, by addition of onium salt generated acids and certain metal salts, such as, for example, aluminum trichloride and ferric chloride, which act as Lewis acids or by addition of lanthanide triflates, see PCT Int. Appl. WO 0008,087.
• Acid catalyzed polymerization of epoxides is a well known method of forming organic polymers and has been applied to epoxy-functional siloxane compounds in order to form sUoxane polyalkyleneoxide block copolymers for use in a variety of applications as, for example, release coatings on paper, see, for example, U.S.
• Patent No.4,279,717 and in conjunction with organic materials to form coatings and modified plastic compositions, see for example, U.S. Patent Nos. 5,354,796 and 5,663,752.
• One precautionary note must be observed, that is if the cationic polymerization is conducted in the presence of cyclic sUoxanes, e.g. D 3/ D 4 or D5 and the like, the strength of the acid catalysis employed must be such that cationic polymerization of the epoxide moiety occurs but polymerization of the cyclic sUoxane does not occur to any appreciable extent.
• the epoxy functional organosUoxane compound is polymerized under cationic cure conditions generated through the interaction with platinum and an SiH-containing compound.
• This epoxide polymerization reaction route is described in U.S. Patent No. 5,128,431 and by J.V. Crivello and N. Fan, J. Polymer Sci., Part A: Polymer Chemistry, pp.1853-1863 (1997).
• the reaction kinetics appear to be dependent upon the presence of trace quantities of molecular oxygen.
• the polyether sUoxane copolymer network compositions of the present invention produce a cross linked structure that possesses a certain amount of steric hindrance by reason of the cross links. This steric hindrance tends to prevent the reaction from going to completion even at long reaction times and thus a certain amount of residual functionaUty may remain.
• This residual functionality provides the abUity to incorporate other functionality into the polyether sUoxane copolymer network by reaction with functionalized molecules that are not as stericaUy constrained as the polyether siloxane copolymer network or it must be chemicaUy inactivated.
• a noble metal hydrosilylation catalyst wiU be present in the reaction mixture or within the interstices of the polyether sUoxane copolymer network.
• This catalyst may be used to further polymerize the oxirane or epoxide moiety (moieties) incorporated in the reaction product producing the polyether sUoxane copolymer network(s) of the present invention.
• the residual functionality remaining by design, i.e. by use of sub-stoichiometric quantities, or by reason of steric inhibition of reaction completion may be further reacted as taught herein or neutralized or inhibited.
• US patents 5,977,280 and 5,929,164 both herein incorporated by reference, teach such neutralization of hydrosUylation catalysts by treatment with strong noble metal complexing
• Ugands for example phosphines, amines and organic sulfur compounds such as organic sulfides and thiols.
• some of these strongly complexing ligands, whUe deactivating a noble metal hydrosUylation catalyst are toxic and thus their use must be avoided in some appUcations, e.g. personal care apphcations.
• sulfur containing amino acid esters are strong noble metal complexing ligands and methionine methyl ester, methionine ethyl ester, cysteine methyl ester, cysteine ethyl ester and cysteine dimethyl ester have been preferred for such noble metal deactivation.
• naturaUy occuring proteins containing disulfide linkages that are easUy disrupted may also be used to deactivate the noble metal catalysts employed, e.g. egg yolks and the like.
• Sulfur containing amino acid amides, polypeptides and the like may also function simUarly to deactivate noble metal hydrosilylation catalysts.
• the method of polymer synthesis provides for incorporation of a wide range of organofunctional groups into the copolymeric structure.
• organofunctional groups such as, for example, organic epoxides, epoxysUoxanes, terminaUy unsaturated organic and alkenylsiloxane compounds can be used to modify the resulting copolymers.
• the organofunctional groups are introduced to the network during polymerization of the epoxyfunctional organosUoxane by including organofunctional compounds to the reaction mixture which are copolymerizable with the epoxy functional organosUoxane under the chosen polymerization reaction conditions.
• polymerization of the epoxy functional organosUoxane is conducted in the presence of one or more organic epoxide compounds which are copolymerizable with epoxy functional hydrido sUoxanes under the polymerization conditions to form mixed polyalkyleneoxide units.
• the additional organic epoxide compounds may contain different substituents to further modify the resulting copolymer.
• Suitable organic epoxide compounds include, for example, ethylene oxide, propylene oxide, butylene oxide, cyclohexene oxide, glycidol and epoxide oUs suchas for example epoxidized soybean oU.
• the polymerization of the epoxy functional organosUoxane is conducted in the presence of one or more hydroxyl functional compounds which are copolymerizable with epoxy functional hydrido sUoxanes under the polymerization conditions to modify the product copolymer.
• Suitable hydroxyl functional compounds include, for example, water, hydroxy-stopped polyethers, organic alcohols, including organic diols, carbinol functional siloxanes and hydroxy functional organopolysiloxane polymers, including polyethersUoxane copolymers.
• the polymerization of the epoxy functional organosUoxane is conducted in the presence one or more alkenyl functional compounds which are copolymerizable with epoxy functional hydrido sUoxanes under the polymerization conditions to modify the product copolymer.
• alkenyl functional compounds include alkenyl functional organic compounds, such as, for example, hexadiene, and alkenyl functional silicone compounds, such as for example, vinyl polydimethylsiloxanes.
• an alkenyl-functional compound may conveniently be added via hydrosUylation in those embodiments in which the cationic reaction conditions for reacting the epoxide groups are generated using platinum and a hydrido-substituted sUoxane, as described above.
• the sUicone composition may be further processed under low to high shear to adjust the viscosity and sensory feel of the composition. This may be achieved, for example, by subjecting the composition to a moderate to high shearing force. High shear may be apphed using, for example, a Sonolator apparatus, a Gaulin Homogenizer or a Micro Fluidizer apparatus. OptionaUy, one or more fluids may be added to the silicone composition prior to the shearing.
• the sUicone composition of the present invention is a solid, typically having a creamy consistency, wherein the copolymer network acts as a means for geUing the fluid to reversibly impart characteristics of a solid to the fluid.
• the silicone composition At rest, the silicone composition exhibits the properties of a solid gel material.
• the sUicone composition of the present invention exhibits high stability and resistance to syneresis, that is, the composition exhibits Uttle or no tendency for fluid to flow from the composition and imparts high stability and syneresis resistance to personal care compositions which include the sUicone composition as a component.
• the high stabUity and syneresis resistance persists with prolonged aging of such sUicone compositions and personal care compositions.
• fluid may be released from the network by subjecting the sUicone composition to a shearing force, such as, for example, by rubbing the composition between one's fingers, to provide improved sensory feel characteristic of the fluid component of the sUicone material.
• Fluids suitable for use as the fluid component of the composition of the present invention are those compounds or mixtures of two or more compounds that are in the Uquid state at or near room temperature, for example, from about 20°C about 50°C, and about one atmosphere pressure, and include, for example, silicone fluids, hydrocarbon fluids, esters, alcohols, fatty alcohols, glycols and organic oils.
• the fluid component of the composition of the present invention exhibits a viscosity of below about 1,000 cSt, preferably below about 500 cSt, more preferably below about 250 cSt, and most preferably below 100 cSt, at 25 °C
• the fluid component of the present invention comprises an emollient compound.
• Suitable emollient compound include any fluid that provides emolUent properties, that is, that when appUed to skin, tend to remain on the surface of the skin or in the stratum corneum layer of the skin to act as lubricants , reduce flaking and to improve the appearance of the skin.
• Emollient compound include, for example, hydrocarbons, such as for example, isododecane, isohexadecane and hydrogenated polyisobutene, organic waxes, such as for example, jojoba, sUicone fluids, such as, for example, cyclopentasUoxane, dimethicone and bis-phenylpropyl dimethicone, esters, such as, for example, octyldodecyl neopentanoate and oleyl oleate, as weU as fatty acids and alcohols, such as for example, oleyl alcohol and isomyristyl alcohol.
• hydrocarbons such as for example, isododecane, isohexadecane and hydrogenated polyisobutene
• organic waxes such as for example, jojoba
• sUicone fluids such as, for example, cyclopentasUoxane, dime
• the fluid component of the present invention comprises a silicone fluid, more preferably a silicone fluid that exhibits emollient properties, preferably a low molecular weight silicone fluid or alternatively a low molecular weight siloxane compound.
• Suitable sUicone fluids include, for example, cyclic silicones of the formula D r , wherein D, R 8 and R 9 are as previously defined, preferably with R 8 and R 9 chosen from the group consisting of monovalent one to six carbon atom monovalent hydrocarbon radicals, more preferably methyl, and r is an integer wherein 3 ⁇ r ⁇ 12, such as, for example, hexamethylcyclotrisiloxane ("D3"), octamethylcyclotetrasiloxane ("D 4 "), decamethylcyclopentasUoxane ("D5"), and dodecamethylcyclohexasUoxane ("DO”) as well as linear or branched organopolysiloxanes having the formula:
• M' is R 19 3 SiO ⁇ / 2 ;
• D' is R 2 ° 2 SiO 2 /2;
• T is R 21 SiO 3 / 2
• R 19 , R 20 and R 21 are each independently alkyl, aryl or aralkyl containing from one to sixty carbon atoms;
• q and s are each independently integers from 0 to 300, preferably from 0 to 100, more preferably from 0 to 50, and most preferably from 0 to 20.
• the sUicone composition of the present invention comprises, per 100 parts by weight ("pbw") of the silicone composition, from 0.1 to 99 pbw, more preferably from 0.5 pbw to 30 pbw and still more preferably from 1 to 15 pbw of the polyether sUoxane copolymer network and from 1 pbw to 99.9 pbw, more preferably from 70 pbw to 99.5 pbw, and still more preferably from 85 pbw to 99 pbw of the fluid.
• pbw per 100 parts by weight
• the polyether sUoxane copolymer network compositions of the present invention may be utilized as prepared or as the silicone component in emulsions.
• emulsions comprise at least two immiscible phases one of which is continuous and the other which is discontinuous. Further emulsions may be liquids with varying viscosities or solids. AdditionaUy the particle size of the emulsions may be render them microemulsions and when sufficiently smaU microemulsions may be transparent. Further it is also possible to prepare emulsions of emulsions and these are generally known as multiple emulsions. These emulsions may be:
• discontinuous phase comprises water and the continuous phase comprises the polyether sUoxane copolymer network of the present invention
• discontinuous phase comprises a non- aqueous hydroxylic solvent and the continuous phase comprises the polyether sUoxane copolymer network of the present invention
• non-aqueous emulsions where the continuous phase comprises a non- aqueous hydroxylic organic solvent and the discontinuous phase comprises the polyether siloxane copolymer network of the present invention.
• Non-aqueous emulsions comprising a silicone phase are described in
• non-aqueous hydroxylic organic compound means hydroxyl containing organic compounds exemplified by alcohols, glycols, polyhydric alcohols and polymeric glycols and mixtures thereof that are liquid at room temperature, e.g. about 25 °C, and about one atmosphere pressure.
• the non-aqueous organic hydroxylic solvents are selected from the group consisting of hydroxyl containing organic compounds comprising alcohols, glycols, polyhydric alcohols and polymeric glycols and mixtures thereof that are liquid at room temperature, e.g. about 25 °C, and about one atmosphere pressure.
• the non-aqueous hydroxylic organic solvent is selected from the group consisting of ethylene glycol, ethanol, propyl alcohol, iso-propyl alcohol, propylene glycol, dipropylene glycol, tripropylene glycol, butylene glycol, iso-butylene glycol, methyl propane diol, glycerin, sorbitol, polyethylene glycol, polypropylene glycol mono alkyl ethers, polyoxyalkylene copolymers and mixtures thereof.
• the resulting material is usuaUy a high viscosity cream with good feel characteristics, and high absorbance of volatUe sUoxanes. It is capable of being blended into formulations for hair care, skin care, antiperspirants, sunscreens, cosmetics, color cosmetics, insect repellants, vitamin and hormone carriers, fragrance carriers and the like.
• the personal care applications where the polyether sUoxane copolymer network of the present invention and the sUicone compositions derived therefrom of the present invention may be employed include, but are not limited to, deodorants, antiperspirants, antiperspirant/ deodorants, shaving products, skin lotions, moisturizers, toners, bath products, cleansing products, hair care products such as shampoos, conditioners, mousses, styling gels, hair sprays, hair dyes, hair color products, hair bleaches, waving products, hair straighteners, manicure products such as naU poUsh, naU polish remover, naUs creams and lotions, cuticle softeners, protective creams such as sunscreen, insect repellent and anti-aging products, color cosmetics such as lipsticks, foundations, face powders, eye liners, eye shadows, blushes, makeup, mascaras and other personal care formulations where sUicone components have been conventionally added, as weU as drug deUvery systems for topical application of
• the personal care composition of the present invention further comprises one or more personal care ingredients.
• Suitable personal care ingredients include, for example, emollients, moisturizers, humectants, pigments, including pearlescent pigments such as, for example, bismuth oxychloride and titanium dioxide coated mica, colorants, fragrances, biocides, preservatives, antioxidants, anti-microbial agents, anti-fungal agents, antiperspirant agents, exfoliants, hormones, enzymes, medicinal compounds, vitamins, salts, electrolytes, alcohols, polyols, absorbing agents for ultraviolet radiation, botanical extracts, surfactants, sihcone oUs, organic oUs, waxes, fUm formers, thickening agents such as, for example, fumed silica or hydrated sUica, particulate fUlers, such as for example, talc, kaolin, starch, modified starch, mica, nylon, clays, such as, for example, bentonite and organo-modified clays.
• pearlescent pigments such as, for example, bis
• Suitable personal care compositions are made by combining, in a manner known in the art, such as, for example, by mixing, one or more of the above components with the polyether sUoxane copolymer network, preferably in the form of the sUicone composition of the present invention.
• Suitable personal care compositions may be in the form of a single phase or in the form of an emulsion, including oU-in-water, water-in-oil and anhydrous emulsions where the sihcone phase may be either the discontinuous phase or the continuous phase, as weU as multiple emulsions, such as, for example, oU- in water-in-oU emulsions and water-in-oU-in water-emulsions.
• an antiperspirant composition comprises the polyether sUoxane copolymer network of the present invention and one or more active antiperspirant agents.
• Suitable antiperspirant agents include, for example, the Category I active antiperspirant ingredients listed in the U.S.
• a skin care composition comprises the polyether siloxane copolymer network, preferably in the form of sUicone composition of the present invention, and a vehicle, such as, for example, a sUicone oil or an organic oU.
• the skin care composition may, optionaUy, further include emollients, such as, for example, triglyceride esters, wax esters, alkyl or alkenyl esters of fatty acids or polyhydric alcohol esters and one or more the known components conventionaUy used in skin care compositions, such as, for example, pigments, vitamins, such as, for example, Vitamin A, Vitamin C and Vitamin E, sunscreen or sunblock compounds, such as, for example, titanium dioxide, zinc oxide, oxybenzone, octylmethoxy cinnamate, butylmethoxy dibenzoylm ethane, p-aminobenzoic acid and octyl dimethyl-p-aminobenzoic acid.
• emollients such as, for example, triglyceride esters, wax esters, alkyl or alkenyl esters of fatty acids or polyhydric alcohol esters and one or more the known components conventionaUy used in skin care compositions
• compositions of the present invention are utilized in conjunction with fragrant materials.
• These fragrant materials may be fragrant compounds, encapsulated fragrant compounds, or fragrance releasing compounds that either the neat compounds or are encapsulated.
• Particularly compatible with the compositions of the present invention are the fragrance releasing silicon containing compounds as disclosed in US patents 6,046,156; 6,054,547; 6,075,111; 6,077,923; 6,083,901; and 6,153,578; aU of which are herein and herewith specificaUy incorporated by reference.
• compositions of the present invention are not restricted to personal care compositions, other products such as waxes, polishes and textiles treated with the compositions of the present invention are also contemplated.
• Preparation Example 1 494.5 g of a hydride fluid with approximate composition M H D3oo D H M H was mixed with 5.5 g of vinyl cyclohexene oxide, 1500 g of decamethyl cyclopentasUoxane (D5), and 0.1 g of a platinum divinyltetramethyldisiloxane catalyst solution. The result was heated to 80 °C. After a couple of hours, an additional portion of platinum catalyst solution was added. The material was heated for a total of 4 hours at 80 °C In this way a gel material ExpMJO-07-391 was obtained with a solids content of about 26% . 567 g of ExpMJO-07-391 was then mixed with 1433 g of additional D5.
• ExpMJO-07-401 had a solids content of about 7.3% and a viscosity of 24,200 cps. This material gave a very silky feel when rubbed on the skin.
• Preparation Example 2 300 g of a hydride fluid with approximate composition M H D337 D H n.sM H was mixed with 3.94 g of vinyl cyclohexene oxide, 37 g of Gulftene C30+ Alpha Olefin Fraction from Chevron (herein defined when a substituent as C30+), 1022.8 g of decamethyl cyclopentasUoxane (D5), and 0.1 g of a platinum divinyltetramethyldisUoxane catalyst solution. The result was heated to 80 °C for 8 hours producing ExpMJO-07-433. This material had a sohds content of about 25.5 % .
• ExpMJO-07-433 was then swollen with 1412.5 g of additional D5 and then passed through a Gaulin homogenizer at 4500 psi.
• the result, ExpMJO-07- 434 had a solids content of about 7.4% and a viscosity of 45,000 cps. It also gave a silky feel when rubbed on the skin.
• ExpMJO-07-422 was then swollen with 1408.6 g of additional D5 and then passed through a Gaulin homogenizer at 4500 psi.
• ExpMJO-07-424 was then swollen with 1408.6 g of additional D5 and then passed through a Gaulin homogenizer at 4500 psi.
• ExpMJO-07-464 533 g was then swoUen with 967 g of additional D5 and then passed through a Gaulin homogenizer at 4500 psi.
• the result, ExpMJO-07-465 had a solids content of about 11% and a viscosity of 200,000 cps.
• Preparation Example 6 300 g of a hydride fluid with approximate composition MDioo D H ⁇ o.sM was mixed with 13.53 g of vinyl cyclohexene oxide, 34.84 g of Gulftene C30+ Alpha Olefin Fraction from Chevron, 647 g of decamethyl cyclopentasUoxane (D5), and 0.10 g of a platinum divinyltetramethyldisUoxane catalyst solution. The result was heated to 80°C for 6 hours producing ExpMJO-07-477. This material had a solids content of about 35.25%.
• ExpMJO-07-464 533 g was then swollen with 947 g of additional D5 and then passed through a Gaulin homogenizer at 4500 psi.
• the result, ExpMJO-07-482 had a solids content of about 12.69% and a viscosity of 16,500 cps.
• Preparation Example 7 316.4 g of a hydride fluid with approximate composition M H D 200 D H _c.5M H was mixed with 7.56 g of vinyl cyclohexene oxide 7.00g of 4-aUyl-2-methoxy-phenol, 840 g of decamethyl cyclopentasUoxane (D5), and 0.09 g of a platinum divinyltetramethyldisUoxane catalyst solution. The result was heated to 80 °C for 6 hours producing ExpMJO-08-537. 418 g of ExpMJO-08-537 was then swollen with 582 g of additional D5 and then passed through a Gaulin homogenizer at 8000 psi. The result, ExpMJO-08-540, had a solids content of about 12% and a viscosity of 198,000 cps.
• 300 g of a hydride fluid with approximate composition M H ⁇ .73D 3 88 D H 6.9Mo.27 was mixed with 3.00 g of vinyl cyclohexene oxide, 4.00 g of 4-aUyl-2-methoxy-phenol, 20.8 g of Gulftene C30+ Alpha Olefin Fraction from Chevron, 984 g of decamethyl cyclopentasUoxane (D5), and 0.1 g of a platinum divinylterramethyl disiloxane catalyst solution. The result was heated to 80 °C for an hour with good mixing.
• ExpMJO-07-481 562 g of ExpMJO-07-481 was then swollen with a mixture of 938 g of additional D5 and 1.0 g of a 10% solution of methyl di(hydrogenated taUow)amine in Isopar C and then passed through a Gaulin homogenizer at 4500 psi.
• antiperspirant sticks were made by heating stearyl alcohol, hydrogenated castor oil, isododecane, SF1202 and ExpMJO-07-465 until the geUants were melted .
• Al Zr Trichlorohydrex gly was added to the batch at 70°C and mixed until uniform.
• Antiperspirants were poured to containers at about 60°C.
• the antiperspirant was evaluated for whiteness, ability to hold liquid, feel, and hardness of the stick. The whiteness was determined by applying antiperspirant onto dark color vinyl slides to mimic the consumer application methods. Vinyl test shdes were air dried for 15 min and the whiteness was determined by appearance.
• the control antiperspirants showed intense whiteness within 5-10 min after application.
• the antiperspirant B showed whiteness reduction as compared to control.
• Antiperspirant B also demonstrated a superior ability to hold cosmetic fluid when using thumb pressure was applied to the sticks. It also improved the rigidity and resiliency of the stick in this formulation. In addition, it provided lubricious skin feel with powdery finish. Formulation B also modified the crystaUization of organic gelling agents by providing a better and more uniform matrix and reducing the growth of stearyl alcohol crystaUization matrix.
• the clear antiperspirant B in this invention showed no syneresis and increased stiffness of the stick compared to control. It gave good pay-out and smooth uniform deposition of antiperspirant active on the skin when compared to control.
• the foundations were prepared by mixing part A and part B together at room temperature until uniform.
• the emulsion was developed when the water phase (Part C) was added into the oU phase.
• the foundation samples were evaluated for coverage on vinyl slides at 24 micron in thickness.
• AU foundations were evaluated on ease of spreadabUity during draw down, appearance, degree of coverage and shine. Shine was determined by using gloss meter after 12 hours.
• formulation B was evaluated against formulation A(control) and formulation D was evaluated against formulation C(control).
• Formulation B gave superior uniform coverage by reducing the appearance of lines and imperfections on the vinyl slides, and by reducing shine during initial rub-out. However, both formulation A and B did not show the difference in gloss after 12 hours. Formulation B imparted a luxurious silky feel with a powdery finish appearance. The foundation B in this invention had improved stabUity after one week at room temperature compared to the formulation A(control) which showed syneresis at the same time.
• Formulation D gave the similar benefits as described in formulation B.
• Formulation D had an ability to control shine as shown in the result above.
• Cetearyl methicone is a linear alkyl substituted silicone and it provides moisturization to the formulation by creating an occlusive barrier on the skin.
• this sUicone moisturizer was combined with the new gel, it showed good compatibUity whereas the SFE839 did not.
• the gel according to this invention is easier to blend with cosmetic ingredients in that it does not require the high shear mixer or lengthy mixing time required by
• This skin treatment gel was prepared by combining all ingredients Usted below until uniform at room temperature.
• the gel was used as deUvery system for skin treatment and it is suitable for both heat sensitive and non- heat sensitive active ingredients since it does not require heating during manufacturing.
• the absence of water in this formulation ensures the efficacy of vitamin C until used.
• a Up treatment comprising ingredients below is useful for contouring, durability and moisturization feel.
• Silky body lotion is made by combining part A together and heating to 80°C. In a separate vessel, part B is mixed and heated to 75°C. The emulsion is formed when part A and part B are added together under high shear mixing. This lotion provides Ught and lubricious skin feel.
• composition A B C D E Composition A B C D E
• Hair shampoo comprising ingredients below gives a sUky feel to hair fibers.
• This shampoo can be prepared into 2 ways; one is directly add sUicone gel to the shampoo, and the other is pre-blend sihcone gel with at least one surfactant and water until emulsion developed and add sUicone gel emulsion to the shampoo.
• This shampoo is made by mixing ingredients as ordered.
• compositions wt%
• Citric acid adjust to pH 6
• This hair conditioner for daUy use provides softness, lubricity and body.
• the leave on hair conditioner reduces fly-away and increases body and volume.
• This soft solid antiperspirant contains sihcone gel an anti-syneresis, thickening and sensory enhancer.
• the gel shows exceUent organic compatibUity. It is used in combination with an organic thickener to achieve the desired texture and rigidity.
• This sihcone hpstick contains sihcone gel to soften hps.
• sihcone gel to soften hps.

Priority Applications (4)

Applications Claiming Priority (2)

Publications (2)

Family

ID=25329205

Family Applications (1)

Country Status (7)

Cited By (3)

Families Citing this family (98)

Citations (4)

Family Cites Families (76)

• 2001
  • 2001-05-16 US US09/858,795 patent/US6538061B2/en not_active Expired - Lifetime
  • 2001-10-31 JP JP2002588967A patent/JP4647190B2/ja not_active Expired - Fee Related
  • 2001-10-31 KR KR1020037014979A patent/KR100870787B1/ko active IP Right Grant
  • 2001-10-31 EP EP01989830A patent/EP1450758B1/en not_active Expired - Lifetime
  • 2001-10-31 CN CNB018232671A patent/CN100558337C/zh not_active Expired - Lifetime
  • 2001-10-31 WO PCT/US2001/045475 patent/WO2002092048A2/en active IP Right Grant
  • 2001-10-31 DE DE60124152T patent/DE60124152T2/de not_active Expired - Lifetime
• 2002
  • 2002-03-22 US US10/103,926 patent/US20030118530A1/en not_active Abandoned
• 2003
  • 2003-03-21 US US10/393,858 patent/US6759479B2/en not_active Expired - Fee Related
• 2004
  • 2004-08-20 US US10/922,487 patent/US20050027051A1/en not_active Abandoned

Patent Citations (4)

Non-Patent Citations (1)

Also Published As

Similar Documents

Legal Events